Your Source for Venture Capital and Private Equity Financings

Nested Therapeutics Launches With $125M Financing.

2022-10-06
CAMBRIDGE, MA, Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform, announced the completion of a $90 million Series A.
Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced the completion of a $90 million Series A financing led by the Life Sciences Investing business within Goldman Sachs Asset Management, bringing the total financing to $125 million since Versant Ventures founded the company. New investors participating in the Series A include Foresite Capital, Avidity Partners, Cowen Healthcare Investments, and Section 32.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading